EP3463458
COMBINED USE OF MARIZOMIB AND BEVACIZUMAB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
1.6.2017EP published:
10.4.2024EP application number:
17730628.9
EPO information:
European Patent Register
Max expiry date:
31.5.2037
Title in English:
COMBINED USE OF MARIZOMIB AND BEVACIZUMAB FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM (CNS) CANCERSLanguage of the patent:
English
Timeline
Today
1.6.2017EP application
10.4.2024EP Publication
Owner
Name:
Celgene Tri A Holdings Ltd.Address:
Aon House 30 Woodbourne Avenue, Pembroke HM 08, BM
Name:
Trikha, MohitAddress:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, US
Name:
Levin, NancyAddress:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, US
Name:
Maclaren, AnnAddress:
3366 N. Torrey Pines Court 210, La Jolla, California 92037, US
Inventor
Name:
TRIKHA, MohitAddress:
La Jolla California 92037, US
Name:
LEVIN, NancyAddress:
La Jolla California 92037, US
Name:
MACLAREN, AnnAddress:
La Jolla California 92037, US
Priority
Number:
201662344194 PDate:
1.6.2016Country:
US
Number:
201662349491 PDate:
13.6.2016Country:
US
Number:
201662362845 PDate:
15.7.2016Country:
US
Number:
201662374136 PDate:
12.8.2016Country:
US
Number:
201662418466 PDate:
7.11.2016Country:
US
Number:
201662424178 PDate:
18.11.2016Country:
US
Number:
201762471321 PDate:
14.3.2017Country:
US
Number:
201762490528 PDate:
26.4.2017Country:
US
Number:
201762491943 PDate:
28.4.2017Country:
US
Classification
Categories:
A61K 39/395, A61K 31/407, A61K 31/495, A61P 35/00, A61P 35/02